167 related articles for article (PubMed ID: 7474444)
21. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
[TBL] [Abstract][Full Text] [Related]
22. Nucleic acid sequence analysis of the precore region of hepatitis B virus from sera of southern African black adult carriers of the virus.
Kramvis A; Bukofzer S; Kew MC; Song E
Hepatology; 1997 Jan; 25(1):235-40. PubMed ID: 8985297
[TBL] [Abstract][Full Text] [Related]
23. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
Bozkaya H; Ayola B; Lok AS
Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
[TBL] [Abstract][Full Text] [Related]
24. Core promoter and precore mutants of hepatitis B virus: prevalence and clinical relevance in chronic hepatitis patients.
Tangkijvanich P; Theamboonlers A; Jantaradsamee P; Hirsch P; Mahachai V; Suwangool P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):627-35. PubMed ID: 11414402
[TBL] [Abstract][Full Text] [Related]
25. HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.
Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Takagi K; Kumada H
J Med Virol; 2003 Jul; 70(3):355-60. PubMed ID: 12766997
[TBL] [Abstract][Full Text] [Related]
26. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
Cho SW; Hahm KB; Kim JH
Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
[TBL] [Abstract][Full Text] [Related]
27. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.
Omata M; Ehata T; Yokosuka O; Hosoda K; Ohto M
N Engl J Med; 1991 Jun; 324(24):1699-704. PubMed ID: 2034246
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
30. Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region.
Hur GM; Lee YI; Suh DJ; Lee JH; Lee YI
J Med Virol; 1996 Jan; 48(1):38-46. PubMed ID: 8825708
[TBL] [Abstract][Full Text] [Related]
31. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
32. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.
Honda A; Yokosuka O; Ehata T; Tagawa M; Imazeki F; Saisho H
J Med Virol; 1999 Apr; 57(4):337-44. PubMed ID: 10089043
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
[TBL] [Abstract][Full Text] [Related]
34. [Gene variation in the pre-C region of hepatitis B virus].
Wang AL; Zhou YX; Yao ZQ
Zhonghua Yi Xue Za Zhi; 1994 Mar; 74(3):144-6, 190. PubMed ID: 7922748
[TBL] [Abstract][Full Text] [Related]
35. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
[TBL] [Abstract][Full Text] [Related]
36. A novel accurate amplification created restriction site method for determination of the wild type and the precore mutant hepatitis B virus variants.
Amini-Bavil-Olyaee S; Sarrami-Forooshani R; Adeli A; Mahboudi F; Sabahi F; Nafisi H; Zali MR; Azizi M
J Virol Methods; 2005 Jul; 127(1):19-23. PubMed ID: 15893561
[TBL] [Abstract][Full Text] [Related]
37. [Association of pre-core defective HBV mutant with anti-HBe positive chronic hepatitis].
Karasawa T; Aizawa Y; Zeniya M; Toda G
Nihon Rinsho; 1993 Feb; 51(2):286-91. PubMed ID: 8464147
[TBL] [Abstract][Full Text] [Related]
38. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
[TBL] [Abstract][Full Text] [Related]
39. Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chimpanzees.
Omi S; Okamoto H; Tsuda F; Mayumi M
J Gastroenterol Hepatol; 1990; 5(6):646-52. PubMed ID: 2129834
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.
Okamoto H; Yotsumoto S; Akahane Y; Yamanaka T; Miyazaki Y; Sugai Y; Tsuda F; Tanaka T; Miyakawa Y; Mayumi M
J Virol; 1990 Mar; 64(3):1298-303. PubMed ID: 2304145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
